A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06934044 · RECRUITING
Trial details
- NCT number
- NCT06934044
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-13
- Primary completion
- 2028-11-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.